Well Done LLC’s LeMaitre Vascular LMAT Stock Holding History

Well Done LLC’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-114	Closed	-$3K	–	419
2018 Q4	$3K	Buy	+114	New	+$3.11K	﹤0.01%	613

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Well Done LLC's LMAT Position: Q1 2019 in Review

Well Done LLC sold out of LeMaitre Vascular (LMAT) in Q1 2019, closing a stake of 114 shares — an estimated $3K sold.

Well Done LLC first reported a position in LMAT in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

Well Done LLC reported no remaining LeMaitre Vascular position as of Q1 2019 after selling out during the quarter.
Well Done LLC sold 114 LeMaitre Vascular shares in Q1 2019, an estimated $3K.
Well Done LLC first reported a position in LeMaitre Vascular in Q4 2018 and held it in 1 quarter.
Well Done LLC's LeMaitre Vascular position peaked at $3K in Q4 2018.
155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.